NeuroOne Medical Technologies Corp’s filing revealed that its Business Development Director Christianson Mark unloaded Company’s shares for reported $45859.0 on Dec 27 ’23. In the deal valued at $1.46 per share,31,445 shares were sold. As a result of this transaction, Christianson Mark now holds 300,594 shares worth roughly $0.35 million.
Then, Christianson Mark sold 6,848 shares, generating $9,269 in total proceeds. Upon selling the shares at $1.35, the Business Development Director now owns 332,039 shares.
Before that, Christianson Mark sold 1,800 shares. NeuroOne Medical Technologies Corp shares valued at $2,520 were divested by the Business Development Director at a price of $1.40 per share. As a result of the transaction, Christianson Mark now holds 338,887 shares, worth roughly $0.4 million.
Craig Hallum downgraded its NeuroOne Medical Technologies Corp [NMTC] rating to a Hold from a a Buy in a research note published on March 29, 2022; the price target was decreased to $2 from $6.
Price Performance Review of NMTC
On Tuesday, NeuroOne Medical Technologies Corp [NASDAQ:NMTC] saw its stock unchanged to $1.17. Over the last five days, the stock has gained 3.54%. NeuroOne Medical Technologies Corp shares have fallen nearly -25.95% since the year began. Nevertheless, the stocks have fallen -17.02% over the past one year. While a 52-week high of $2.00 was reached on 01/02/24, a 52-week low of $0.85 was recorded on 02/15/24. SMA at 50 days reached $1.1756, while 200 days put it at $1.1744. A total of 0.83 million shares were traded, compared to the trading of 45800.0 shares in the previous session.
Levels Of Support And Resistance For NMTC Stock
The 24-hour chart illustrates a support level at 1.1233, which if violated will result in even more drops to 1.0767. On the upside, there is a resistance level at 1.2533. A further resistance level may holdings at 1.3367. The Relative Strength Index (RSI) on the 14-day chart is 50.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0200, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.16%. Stochastics %K at 49.96% indicates the stock is a holding.
